{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-033842","form_type":"8-K","ticker":"IXHL","cik":"0001873875","company_name":"Incannex Healthcare Inc.","filed_at":"2026-03-25T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.638417+00:00","generated_at":"2026-05-15T09:04:25.354197+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Incannex partners with AASM Foundation, sponsors junior investigator sleep apnea grant","bullets":["Partnership with AASM Foundation Corporate Recognition Program to support sleep apnea research.","Sponsors a Focused Projects Grant for Junior Investigators in Diagnosis, Management, and Treatment of Sleep Apnea, to be awarded in 2026.","IHL-42X Phase 2 DReAMzz study patient dosing expected within coming months; Phase 3 pathway defined.","Previous milestones: positive Phase 2 results, FDA Fast Track designation, and establishment of Clinical Advisory Board."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-033842","json":"https://secwatch.observer/filing/0001213900-26-033842.json","markdown":"https://secwatch.observer/filing/0001213900-26-033842.md","text":"https://secwatch.observer/filing/0001213900-26-033842.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1873875/000121390026033842/0001213900-26-033842-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1873875/000121390026033842/ea028334201-8k_incannex.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T09:04:25.354197+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}